Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Search Results

Showing 51 - 60 of 238 results for "Pharmaceutical"

Chi-X TraCRs added to specialist platform

ALLY SELBY  |  WEDNESDAY, 5 AUG 2020
... teleconferencing provider Zoom, protective healthcare equipment producer 3M, global payments giant Mastercard and pharmaceutical company Gilead Sciences. WealthO2 co-founder and managing director Shannon Bernasconi said the new low cost and innovative ...

Super reform should happen, but not now: Grattan

ELIZA BAVIN  |  THURSDAY, 2 JUL 2020
... like to reform superannuation, capital gains taxes and stamp duties, or make hospitals more efficient, or reduce pharmaceutical and pathology prices, this is not going to happen - and it shouldn't - for six months or more," he said. "And if your wish ...

Chi-X releases viral TraCRs stocks

ALLY SELBY  |  THURSDAY, 25 JUN 2020
... protective healthcare equipment provider 3M, payments giant Mastercard, supermarket conglomerate Walmart and anti-viral pharmaceutical company Gilead Sciences. Following today's announcement, there are now 35 US listed companies available to Australian ...

GDP figures reveal start of COVID-19 impact

ELIZA BAVIN  |  WEDNESDAY, 3 JUN 2020
The Australian Gross Domestic Product fell 0.3%, seasonally adjusted, in the March quarter and growth slowed to 1.4% through the year, according to figures released by the Australian Bureau of Statistics. ABS chief economist Bruce Hockman said this ...

Opportunities abound in COVID-19 environment

ALLY SELBY  |  WEDNESDAY, 6 MAY 2020
The uncertainty and volatility that COVID-19 has endowed on markets has opened up opportunities not seen in decades, according to a $9.5 billion Aussie investment manager. However, in order to take advantage of these opportunities investors must be ...

Times of turmoil create opportunities: deVere

ALLY SELBY  |  WEDNESDAY, 25 MAR 2020
... unprecedented - job and investment opportunities in others." He pointed to big tech as a likely winner, as well as pharmaceutical and healthcare firms, delivery brands, supermarkets and manufacturers of electronic goods. Green said the world would "of ...

Evans Dixon hires former Macquarie chair

KANIKA SOOD  |  FRIDAY, 28 FEB 2020
Evans Dixon has hired a former Macquarie Group chair as a non-executive director, as it reports a slump in profits and lays off more than 120 staff. Kevin McCann is joining the board effectively immediately, Evans Dixon said in company filings this ...

New fund invests $45m in SA

ELIZA BAVIN  |  FRIDAY, 17 JAN 2020
A new fund has invested $45 million into the South Australian health and biotech industries. The Chinese fund has invested the money to accelerate the development and commercialization of health and medical research outcomes from South Australia. The ...

US private investment firm appoints first Aussie partner

ALLY SELBY  |  TUESDAY, 14 JAN 2020
... (which owns Boost, Salsa's, Cibo and Betty's Burgers). They also hold investments in Asia Pacific Medical Group and pharmaceutical company Emcure, as well as wind power developer JWD.

Purdue bankruptcy vindicates ESG screens

ELIZABETH MCARTHUR  |  MONDAY, 23 SEP 2019
... bonds work and what their exposures might be through them. Schroders has conducted substantial research around pharmaceutical companies and opioids in order to create ESG screens that ensure it is not exposed to cases like Purdue's. The Schroders research ...